Questioning Medicine
Questioning Medicine
Questioning Medicine
173. Uterine Fibroid Symptoms, HPV Vaccine, Copper IUD, Colchicine
24 minutes Posted Mar 29, 2021 at 3:11 pm.
ratio to receive once-daily placebo, relugolix combination therapy (40 mg of relugolix, 1 mg of estradiol, and 0.5 mg of norethindrone acetate), or delayed relugolix combination therapy (40 mg of relugolix monotherapy, followed by relugolix combination therapy, each for 12 weeks).
0:00
24:47
Download MP3
Show notes
Uterine Fibroid and heavy bleeding might have a new drug if your normal drug was giving placebo. HPV Vaccine is still awesome and very very safe. Copper IUD has a new kid in town when it comes to emergency contraception and Colchicine should not be used for secondary prevention (at least not when I read the trial)
HTTPS://WWW.NEJM.ORG/DOI/FULL/10.1056/NEJMOA2008283
Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy
international, double-blind, 24-week, phase 3 trials involving women with fibroid-associated heavy menstrual bleeding.
Participants were randomly assigned in a
The primary efficacy end point in each trial was the percentage of participants with a response (volume of menstrual blood loss 12 times/year) were
2.5 times more likely to be current smokers, to consume >14 alcoholic drinks/week, and to drink >6 cups of coffee daily. AND THERE WAS A –response relationship with increasing tanning frequency.
Many of you will know that a dose response relationshop is one of the keys for causation in observational studies. So could it be the tanning causes the smoking, drinking, and coffee drinking.. not directly. But could it be that the personality traits that cause you do go above and beyond are active in all actions of your life?? YES
When you go above and beyong you go above and beyond for everything—its almost never something like well I am crazy about working out but I eat like garbage and vice versa if you eat terrible rarely are you crazy about working out. You burn it at both ends of the stick or you don’t the problem is controlling it in a healthy way which is maybe the key to life.
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2775955?guestAccessKey=d35250c2-a79e-486c-80e9-67a886cb9ef1&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamainternalmedicine&utm_content=olf&utm_term=021521
#FDA tells the companies but the companies don't tell the public! (thread) #MedTwitter This should be a #publichealth issue.
@MedTweetorials
If there is question related to a drug products quality, safety, and efficacy then the FDA will issue a "refuse-to-file" to the COMPANY not to the public. However, shouldn't their be transparency?
Over a decade ago the #FDA even had a task force for more transparency! https://fdanews.com/ext/resources/files/archives/f/FDA-2009-N-0247-0107.1.pdf
https://www.fdanews.com/ext/resources/files/archives/f/FDA-2009-N-0247-0107.1.pdf
I will say a "refuse-to-file" is a rare event (thank goodness). Between 2008-2017 only 4% or 103 out of 2475 applications received a refuse to file. BUT guess how many times the public was informed of these "refuse-to-file"?
15.5% of the time! Only 16/103! This is TERRIBLE!
It may come as no surprise that NONE of these "refuse-to-file" letters were were published in their entirety but rather as a press release or abbreviated form.
Just like there was a large push as one time for authors to post or register their #clinicaltrials I think there should be equal push for companies to register and publish their "refuse-to-file" letters.
I didn’t know only copper IUD!!
The New England Journal of Medicine
Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception
N. Engl. J. Med 2021 Jan 28;384(4)335-344, DK Turok, A Gero, RG Simmons, JE Kaiser, GJ Stoddard, CD Sexsmith, LM Gawron, JN Sanders
In this trial, the researchers randomized women to a copper IUD or levonorgestrel IUD for emergency contraception and found the levonorgestrel IUD to be noninferior to the copper for this purpose.
In the (continued)